Thrombolex, Inc.’s Post

Endovascular thrombectomy for acute ischaemic stroke with established large infarct (TENSION): 12-month outcomes of a multicentre, open-label, randomised trial. Interpretation In patients with acute ischaemic stroke from large vessel occlusion with established large infarct, compared with medical treatment only, endovascular thrombectomy was associated at 12 months after stroke with better functional outcome, quality of life, and overall survival. These findings suggest that the benefits of endovascular thrombectomy in patients with an ischaemic stroke and a large infarct are sustained in the long term and support the use of endovascular thrombectomy in these patients. #TENSION #Stroke #endovascular #treatment #LVO

Compelling results of the RESCUE II Clinical Trial were recently presented during TCT 2024. Dr. Christian Bichard shared data from patients with acute intermediate-risk pulmonary embolism (PE) treated with the BASHIR™ Endovascular Catheter. Conducted at Temple University by Drs. Riyaz Bashir and Vladimir Lakhter, the study highlights the effectiveness of single-session pharmacomechanical lysis (PML) without the need for post-procedural thrombolytic infusion. #Thrombolex https://lnkd.in/eNUhhr37

Good news for patients with tricuspid regurgitation: the latest insights from the TRI-fr trial presented at the #ESCCongress show once again that treatment with the #TriClip Transcatheter Tricuspid Valve Repair System is superior to medical therapy alone. Key takeaways: - In severe tricuspid regurgitation, the tricuspid valve does not close properly and this can alter kidney and liver function, and cause disabling symptoms. -T-TEER plus optimal medical therapy resulted in a significant improvement of the primary endpoint including death, cardiovascular hospitalisation, functional class and patient-reported outcomes. - T-TEER plus optimal medical therapy was associated with major quality-of-life improvements. Learn more: https://lnkd.in/eFJxn7i3 #AbbottProud #StructuralHeart #TTEER

Approximately 50% of patients with ST elevation myocardial infarction treated with percutaneous coronary intervention experience microvascular no-reflow. Pre- and post-PCI sonothrombolysis has been shown to decrease infarct size and improve left ventricular systolic function in STEMI patients receiving urgent PCI. Find out whether post-PCI sonothrombolysis alone in STEMI patients with persistent ST elevation alone can reduce no-reflow and infarct size in our recent JASE article, "Sonothombolysis in Patients With ST-Elevation Myocardial Infarction With Electrocardiographic No-Reflow After Percutaneous Coronary Intervention: A Randomized Controlled Trial" here: https://bit.ly/4h0X6a7.

CX 2024 welcomes a revolutionised Carotid and Acute Stroke programme (Wednesday 24 April) which, for the first time, expands upon carotid indications, new technologies and neurointeventions. Take a look at the series of upcoming debates below! 🆕 Domenico Valenti 🗣️ Debate: Patients with symptomatic near occlusion in the internal carotid artery (ICA) should only be treated medically Konstantinos Antonopoulos Rantner Barbara, MD, PhD, FEBVS 🗣️ Debate: Best medical treatment (BMT) only is as effective as carotid endarterectomy (CEA) or carotid artery stenting (CAS) in patients with symptomatic internal carotid artery (ICA) stenosis Melina De Vega De Ceniga 🗣️ Debate: Patients with symptomatic carotid artery web should only be treated medically Maarit Venermo 🗣️ Debate: CAS is the treatment of choice for underlying ICA stenosis after mechanical thrombectomy 🗣️ Debate: Patients with vertebro-basilar ischaemia should be treated with endovascular intervention Levansri Makalanda ➡️ View the programme in full: https://lnkd.in/eBiwitAf

More big news from the #ESCCongress: In complex PCI cases, OCT-guidance significantly improves clinical outcomes and enhances safety and effectiveness of coronary stenting compared to angiography, as seen in the OCCUPI Trial. Key points to remember: 1️⃣ OCT-guided PCI reduced composite of cardiac death, myocardial infarction (MI), stent thrombosis (ST) & ischemia-driven target vessel revascularization (ID-TVR) by 38% in complex lesions at 1 year compared to angiography. 2️⃣ OCT-guided group patients were 64% less likely to experience a spontaneous MI or require target-vessel revascularization than the angio-guided group. 3️⃣ There was no difference in incidence of contrast-induced nephropathy after PCI between the 2 groups. This new data along with the #ESCguidelines change for image-guided PCI to Class 1A further supports superiority of imaging over angiography. Safety Info: www.bit.ly/ISI_info

What is lung diffusion testing (DLCO)?   Lung diffusion testing is a type of pulmonary function test that determines how well oxygen moves from the lungs to the blood. It helps healthcare providers understand how well the lungs are working.   DLCO, which is measured using a test gas with a small amount of carbon monoxide, reflects the ability of the lungs to exchange gas into the bloodstream. DLCO is diminished in emphysema, interstitial lung disease, pulmonary vascular disease, and anemia.   There are patients in all countries of the world who may have the corresponding diagnostic methods, while others have not been touched by advanced and effective diagnostic methods.   As a medical device distributor, do you need to provide doctors and patients with more advanced and effective medical diagnostic methods? Do you want them to benefit from the technology brought by scientific and technological progress?   If so, please contact us to obtain the distribution rights of Pulmonary function testing machine for DLCO. WhatsApp 0086 187 1634 4242   #singlebreathdlco #lungdiffusioncapacity #emphysema #interstitiallungdisease #pulmonaryvasculardisease #anemia #spirometer #pft #pulmonologist #pulmonology #chestdiseases #copd #dlco #lungcare #lunghealth #lungclinic #medicaldevice #medicaldistributor #DLCO #medicaldevice #testingequipment #medicaldevicemaufacturer #longcovid #CPET #healthcare #medicine #chronicdisease #chronicdiseasemanagement #lungfunctiontesting #bronchoscopy #interventionalpulmonology #lungcancerscreening    

What is lung diffusion testing (DLCO)?   Lung diffusion testing is a type of pulmonary function test that determines how well oxygen moves from the lungs to the blood. It helps healthcare providers understand how well the lungs are working.   DLCO, which is measured using a test gas with a small amount of carbon monoxide, reflects the ability of the lungs to exchange gas into the bloodstream. DLCO is diminished in emphysema, interstitial lung disease, pulmonary vascular disease, and anemia.   There are patients in all countries of the world who may have the corresponding diagnostic methods, while others have not been touched by advanced and effective diagnostic methods.   As a medical device distributor, do you need to provide doctors and patients with more advanced and effective medical diagnostic methods? Do you want them to benefit from the technology brought by scientific and technological progress?   If so, please contact us to obtain the distribution rights of Pulmonary function testing machine for DLCO. WhatsApp 0086 187 1634 4242   #singlebreathdlco #lungdiffusioncapacity #emphysema #interstitiallungdisease #pulmonaryvasculardisease #anemia #spirometer #pft #pulmonologist #pulmonology #chestdiseases #copd #dlco #lungcare #lunghealth #lungclinic #medicaldevice #medicaldistributor #DLCO #medicaldevice #testingequipment #medicaldevicemaufacturer #longcovid #CPET #healthcare #medicine #chronicdisease #chronicdiseasemanagement #lungfunctiontesting #bronchoscopy #interventionalpulmonology #lungcancerscreening    

Aortic stenosis isn’t just a disease of the valve. In this video, Dr. João Cavalcante and Dr. Christopher Meduri discuss the upstream and downstream impacts on the cardiovascular system and implications for aortic stenosis treatment. At Anteris, we are dedicated to moving the conversation forward in TAVR and taking a whole-heart perspective to assess valve performance and define success in TAVR. #aorticstenosis #interventionalcardiology #TAVI #TAVR #MovingtheConversationForward DurAVR® INVESTIGATIONAL USE ONLY. NOT AVAILABLE FOR COMMERCIAL SALE.  EU: Exclusively for clinical investigations. US: CAUTION – Investigational Device. Limited by Federal (or United States) law to investigational use. 

What is lung diffusion testing (DLCO)? Lung diffusion testing is a type of pulmonary function test that determines how well oxygen moves from the lungs to the blood. It helps healthcare providers understand how well the lungs are working.   DLCO, which is measured using a test gas with a small amount of carbon monoxide, reflects the ability of the lungs to exchange gas into the bloodstream. DLCO is diminished in emphysema, interstitial lung disease, pulmonary vascular disease, and anemia. There are patients in all countries of the world who may have the corresponding diagnostic methods, while others have not been touched by advanced and effective diagnostic methods. As a medical device distributor, do you need to provide doctors and patients with more advanced and effective medical diagnostic methods? Do you want them to benefit from the technology brought by scientific and technological progress? If so, please contact us to obtain the distribution rights of Pulmonary function testing machine for DLCO. WhatsApp 0086 187 1634 4242 #singlebreathdlco #lungdiffusioncapacity #emphysema #interstitiallungdisease #pulmonaryvasculardisease #anemia #spirometer #pft #pulmonologist #pulmonology #chestdiseases #copd #dlco #lungcare #lunghealth #lungclinic #medicaldevice #medicaldistributor #DLCO #medicaldevice #testingequipment #medicaldevicemaufacturer #longcovid #CPET #healthcare #medicine #chronicdisease #chronicdiseasemanagement #lungfunctiontesting #bronchoscopy #interventionalpulmonology #lungcancerscreening